FGP
NHI icon

Freestone Grove Partners’s National Health Investors NHI Stock Holding History

Freestone Grove Partners’s Portfolio NHI Stock Details NHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Sell
30,673
-227,350
-88% -$17.4M 0.02% 402
2026
Q1 		$20.9M Sell
258,023
-28,332
-10% -$2.36M 0.15% 202
2025
Q4 		$21.9M Buy
+286,355
New +$22M 0.16% 195

Other funds holding NHI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Freestone Grove Partners's NHI Position: Q2 2026 in Review

Freestone Grove Partners reduced its National Health Investors (NHI) stake by 88% in Q2 2026, selling an estimated $17.4M and leaving 30,673 shares worth $2.34M. The position accounts for 0.02% of the portfolio, ranked #402.

Freestone Grove Partners first reported a position in NHI in Q4 2025 and has held it in 3 quarters since. The position peaked at $21.9M in Q4 2025. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Freestone Grove Partners held 30,673 shares of National Health Investors worth $2.34M as of Q2 2026.
  • Freestone Grove Partners sold 227,350 National Health Investors shares in Q2 2026, an estimated $17.4M.
  • National Health Investors made up 0.02% of Freestone Grove Partners's portfolio in Q2 2026, its #402 holding.
  • Freestone Grove Partners first reported a position in National Health Investors in Q4 2025 and has held it in 3 quarters since.
  • Freestone Grove Partners's National Health Investors position peaked at $21.9M in Q4 2025.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.